Key Dates

Related Announcements

RFA-CA-20-038 - Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)

RFA-CA-20-039 - Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

NCI will hold a pre-application webinar on June 18, 2020 at 1:00 p.m. – 2:30 p.m. (ET) for Funding Opportunity Announcements (FOA) RFA-CA-20-038 and RFA-CA-20-039 associated with NCI’s Serological Sciences Network (SeroNet). This pre-application webinar will be focused on introducing the multiple components of SeroNet and answering questions about the SARS-CoV-2 Serological Sciences Centers of Excellence (U54) FOA and the Research Projects in SARS-CoV-2 Serological Sciences (U01) FOA.

NCI staff involved in these FOAs will provide orientation and technical assistance to potential applicants to the above-referenced FOAs by explaining the goals and objectives for the FOAs and answer questions from webinar attendees.

Potential applicants are encouraged to submit their questions by June 16, 2020 to [email protected].

Note: Questions about the scope of the FOAs will be addressed during the webinar; however, questions about investigators’ specific study aims will not be addressed in the webinar.

When it’s time, follow this link to join the Webex meeting. Participants are encouraged to join early to ensure connectivity.

Participation in this webinar, although encouraged for potential applicants, is optional, and is not required for the submission of an application in response to RFA-CA-20-038 or RFA-CA-20-039.

Any questions about the webinar should be directed to [email protected].

Inquiries

Please direct all inquiries to:

Juli Klemm, Ph.D.
National Cancer Institute (NCI)
Telephone: 301-480-5778
Email:[email protected]

Samantha Finstad, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6460
Email: [email protected]